• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性自发性荨麻疹患者T细胞受体多样性降低及克隆性扩增序列

Diminished Diversities and Clonally Expanded Sequences of T-Cell Receptors in Patients with Chronic Spontaneous Urticaria.

作者信息

He Xian, Wen Xueping, He Peng Ming, Liang Dan, Yang Lihong, Ran Yuping, Zhang Zhixin

机构信息

Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Department of Allergy, Chengdu First People's Hospital, Chengdu, People's Republic of China.

出版信息

Immunotargets Ther. 2024 Dec 5;13:661-671. doi: 10.2147/ITT.S481361. eCollection 2024.

DOI:10.2147/ITT.S481361
PMID:39659518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11628316/
Abstract

OBJECTIVE

Studies establish a link between autoimmune factors and chronic spontaneous urticaria (CSU). T cells are crucial in immune-mediated diseases like CSU, and T-cell receptor (TCR) diversity could be pivotal in autoimmune responses. The clinical relevance of TCR variations in CSU is unknown, but understanding them may offer insights into CSU's pathogenesis and treatment.

METHODS

This cross-sectional study included 132 chronic urticaria (CU) patients versus 100 age-matched healthy donors (HD), with subgroup analyses on CU type, angioedema, allergic comorbidities, and anti-IgE therapy efficacy. Peripheral TCRβ repertoires were analyzed by high-throughput sequencing.

RESULTS

CSU patients showed reduced TCR diversity (lower D50) and increased large clone proportions than HD. Moreover, TCR diversity in CSU patients was significantly lower than in those with Chronic Inducible Urticaria (ClndU). There were also differences in variable (V) and joining (J) gene usage between CU and HD groups as well as CSU and ClndU groups. However, in subgroup analyses regarding angioedema, allergic comorbidities, and the efficacy of anti-IgE treatment, no significant differences were found in TCR diversity or large TCRβ clones. Notably, patients with treatment relapse or poor response to anti-IgE therapy had a higher proportion of positively charged CDR3. Additionally, age affected TCR diversity, but TIgE value, EOS counts, CU duration, and UAS7 score did not associate significantly with D50.

CONCLUSION

CSU patients exhibit reduced TCR diversity and increased large clone proportions, indicating abnormal T cell activation. The TCR diversity differences and distinct V and J gene usage between CSU and ClndU may indicate different mechanisms in T lymphocyte-associated immune responses for these two subtypes of CU. The higher positive charge in CDR3 of relapsed or poorly responsive patients to anti-IGE treatment may indicate more antigen charge involvement. These findings provide new insights into the pathogenesis of CSU and potential future treatments.

摘要

目的

研究证实自身免疫因素与慢性自发性荨麻疹(CSU)之间存在联系。T细胞在CSU等免疫介导性疾病中起关键作用,而T细胞受体(TCR)多样性可能在自身免疫反应中起关键作用。CSU中TCR变异的临床相关性尚不清楚,但了解这些变异可能有助于深入了解CSU的发病机制和治疗方法。

方法

这项横断面研究纳入了132例慢性荨麻疹(CU)患者和100例年龄匹配的健康供体(HD),并对CU类型、血管性水肿、过敏性合并症和抗IgE治疗疗效进行了亚组分析。通过高通量测序分析外周血TCRβ库。

结果

与HD相比,CSU患者的TCR多样性降低(D50较低)且大克隆比例增加。此外,CSU患者的TCR多样性显著低于慢性诱导性荨麻疹(ClndU)患者。CU组和HD组以及CSU组和ClndU组之间在可变(V)基因和连接(J)基因的使用上也存在差异。然而,在关于血管性水肿、过敏性合并症和抗IgE治疗疗效的亚组分析中,TCR多样性或大TCRβ克隆未发现显著差异。值得注意的是,治疗复发或对抗IgE治疗反应不佳的患者带正电荷的CDR3比例较高。此外,年龄影响TCR多样性,但TIgE值、嗜酸性粒细胞计数、CU病程和UAS7评分与D50无显著相关性。

结论

CSU患者表现出TCR多样性降低和大克隆比例增加,表明T细胞活化异常。CSU和ClndU之间的TCR多样性差异以及不同的V和J基因使用可能表明这两种CU亚型在T淋巴细胞相关免疫反应中的机制不同。复发或对抗IGE治疗反应不佳的患者CDR3中较高的正电荷可能表明更多的抗原电荷参与。这些发现为CSU的发病机制和未来潜在治疗提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11628316/7c62597fe59a/ITT-13-661-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11628316/9d0c8c01175c/ITT-13-661-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11628316/9e42108e2be9/ITT-13-661-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11628316/1473eab5205f/ITT-13-661-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11628316/7fe299d67bba/ITT-13-661-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11628316/7c62597fe59a/ITT-13-661-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11628316/9d0c8c01175c/ITT-13-661-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11628316/9e42108e2be9/ITT-13-661-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11628316/1473eab5205f/ITT-13-661-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11628316/7fe299d67bba/ITT-13-661-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956b/11628316/7c62597fe59a/ITT-13-661-g0005.jpg

相似文献

1
Diminished Diversities and Clonally Expanded Sequences of T-Cell Receptors in Patients with Chronic Spontaneous Urticaria.慢性自发性荨麻疹患者T细胞受体多样性降低及克隆性扩增序列
Immunotargets Ther. 2024 Dec 5;13:661-671. doi: 10.2147/ITT.S481361. eCollection 2024.
2
Atopy and Response to Omalizumab Treatment in Chronic Spontaneous Urticaria.特应性与奥马珠单抗治疗慢性自发性荨麻疹的反应。
Int Arch Allergy Immunol. 2024;185(3):260-266. doi: 10.1159/000535414. Epub 2023 Dec 19.
3
Biomarkers of Autoimmune Chronic Spontaneous Urticaria.自身免疫性慢性自发性荨麻疹的生物标志物。
Curr Allergy Asthma Rep. 2023 Dec;23(12):655-664. doi: 10.1007/s11882-023-01117-7. Epub 2023 Dec 8.
4
Analysis of the Efficacy and Recurrence of Omalizumab Use in the Treatment of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria.奥马珠单抗治疗慢性自发性荨麻疹和慢性诱导性荨麻疹的疗效和复发分析。
Int Arch Allergy Immunol. 2023;184(7):643-655. doi: 10.1159/000529250. Epub 2023 Mar 30.
5
Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.奥马珠单抗对慢性荨麻疹患者外周血 T 细胞的调节作用。
Front Immunol. 2024 Aug 20;15:1413233. doi: 10.3389/fimmu.2024.1413233. eCollection 2024.
6
Decoding the variability in clinical and laboratory profiles of Chronic Inducible Urticaria vs. Chronic Spontaneous Urticaria - a retrospective study from a tertiary care center.解析慢性诱导性荨麻疹与慢性自发性荨麻疹的临床和实验室特征变异性-来自三级护理中心的回顾性研究。
Arch Dermatol Res. 2024 Oct 22;316(10):703. doi: 10.1007/s00403-024-03447-6.
7
IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria?针对甲状腺过氧化物酶的 IgE 介导的自身过敏反应——慢性自发性荨麻疹的新发病机制?
PLoS One. 2011 Apr 12;6(4):e14794. doi: 10.1371/journal.pone.0014794.
8
Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights.共病性诱导性荨麻疹与非自身免疫性慢性自发性荨麻疹相关:CURE研究见解
J Allergy Clin Immunol Pract. 2024 Feb;12(2):482-490.e1. doi: 10.1016/j.jaip.2023.11.029. Epub 2023 Nov 24.
9
Characteristics and Clinical Significance of Atopy in Chronic Spontaneous Urticaria: A Cross-Sectional Observational Study.慢性自发性荨麻疹中特应性的特征及临床意义:一项横断面观察研究
Int Arch Allergy Immunol. 2024;185(12):1248-1253. doi: 10.1159/000540155. Epub 2024 Jul 30.
10
Analysis of clinical factors as possible predictors of response to omalizumab and relapse after treatment discontinuation in chronic spontaneous urticaria.分析可能预测慢性自发性荨麻疹患者对奥马珠单抗治疗应答和停药后复发的临床因素。
Dermatol Ther. 2022 Feb;35(2):e15248. doi: 10.1111/dth.15248. Epub 2021 Dec 16.

本文引用的文献

1
Evaluation and comparison of adaptive immunity through analyzing the diversities and clonalities of T-cell receptor repertoires in the peripheral blood.通过分析外周血 T 细胞受体库的多样性和克隆性来评估和比较适应性免疫。
Front Immunol. 2022 Sep 8;13:916430. doi: 10.3389/fimmu.2022.916430. eCollection 2022.
2
Urticaria.荨麻疹。
Nat Rev Dis Primers. 2022 Sep 15;8(1):61. doi: 10.1038/s41572-022-00389-z.
3
The Role of Crosstalk of Immune Cells in Pathogenesis of Chronic Spontaneous Urticaria.免疫细胞串扰在慢性自发性荨麻疹发病机制中的作用。
Front Immunol. 2022 May 31;13:879754. doi: 10.3389/fimmu.2022.879754. eCollection 2022.
4
T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19.T 细胞受体谱可作为 COVID-19 患者的潜在诊断标志物。
Int J Infect Dis. 2021 Dec;113:308-317. doi: 10.1016/j.ijid.2021.10.033. Epub 2021 Oct 22.
5
Extracellular Vesicles as Emerging Players in Intercellular Communication: Relevance in Mast Cell-Mediated Pathophysiology.细胞外囊泡作为细胞间通讯中的新兴参与者:在肥大细胞介导的病理生理学中的相关性。
Int J Mol Sci. 2021 Aug 25;22(17):9176. doi: 10.3390/ijms22179176.
6
T Cell Receptor Beta-Chain Profiling of Tumor Tissue, Peripheral Blood and Regional Lymph Nodes From Patients With Papillary Thyroid Carcinoma.甲状腺乳头状癌患者肿瘤组织、外周血和区域淋巴结的 T 细胞受体β链分析。
Front Immunol. 2021 Feb 18;12:595355. doi: 10.3389/fimmu.2021.595355. eCollection 2021.
7
Comprehensive T cell repertoire characterization of non-small cell lung cancer.非小细胞肺癌的全面 T 细胞受体谱特征。
Nat Commun. 2020 Jan 30;11(1):603. doi: 10.1038/s41467-019-14273-0.
8
Analysis of the B cell receptor repertoire in six immune-mediated diseases.分析六种免疫介导性疾病中的 B 细胞受体库。
Nature. 2019 Oct;574(7776):122-126. doi: 10.1038/s41586-019-1595-3. Epub 2019 Sep 25.
9
IL-6 and IL-1β expression is increased in autologous serum skin test of patients with chronic spontaneous urticaria.慢性自发性荨麻疹患者自体血清皮肤试验中白细胞介素-6和白细胞介素-1β表达增加。
Allergy. 2019 Dec;74(12):2522-2524. doi: 10.1111/all.13928. Epub 2019 Jun 20.
10
T cell receptor β repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis.T 细胞受体 β 谱作为系统性红斑狼疮和类风湿关节炎的新型诊断标志物。
Ann Rheum Dis. 2019 Aug;78(8):1070-1078. doi: 10.1136/annrheumdis-2019-215442. Epub 2019 May 17.